Anti-Diabetic Medications to Fight PD and LBD

• Status: ACTIVE_NOT_RECRUITING
• Trial end date: 2025-08-30

Summary

The purpose of this study is to test the hypothesis that DPP4 inhibitors and SGLT2 inhibitors are well tolerated and have beneficial neurological effects, specifically for Parkinson's disease and Lewy body dementia.

• Phase: PHASE4

Details

• Lead Sponsor: Mayo Clinic
• Treatments: dapagliflozin; Sitagliptin Phosphate